source
- Merck's Welireg and Keytruda combo receives FDA approval for adjuvant kidney cancer therapyMerck announced that its combination of the oral VEGFR inhibitor Welireg and the immunotherapy Keytruda has been cleared by the U.S. Food and Drug Administration. The clearance applies to patients…
- GSK completes $10.6 billion acquisition of Nuvalent, the largest in its historyGSK announced it has completed a $10.6 billion purchase of Nuvalent, marking the biggest deal the company has ever undertaken. The transaction was disclosed on Tuesday and values Nuvalent at $124…